Forensic Analysis · General / Diversified · as of Jun 28, 2026
Electromed, Inc. (ELMD)
A forensic read on Electromed, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
B · Sound & dependable
Forensic grade
Safe
Financial health
11.0
Altman Z-score
Clean
Earnings quality
2
Forensic signals
34.0
P / E (ttm)
22.1%
ROE
$343M
Market cap
Electromed, Inc. earns a B (Sound & dependable) forensic quality grade, and its Altman Z-score is 11.0, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by share-count dilution.
What the filings flag
+0.6%/yrShare-count dilution.Diluted share count changed +2% over the last 3 years to FY2025 (+0.6%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
5% of revStock-based comp load.Stock-based compensation ran 5% of revenue and 27% of free cash flow in FY2025 — about $0.34 per diluted share. Meaningful — reported free cash flow flatters the economics, since SBC is a real cost paid in shares.
Key fundamentals
Net Margin11.8%
Debt / Equity0.03x
Free Cash Flow$11.1M
Latest Revenue$64.0M
Return on Equity17.4%
Revenue Growth YoY+17.0%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on Electromed, Inc.:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about ELMD's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown